Abbvie Endocrine Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBVIE ENDOCRINE INC, and when can generic versions of ABBVIE ENDOCRINE INC drugs launch?
ABBVIE ENDOCRINE INC has six approved drugs.
There are two US patents protecting ABBVIE ENDOCRINE INC drugs.
There are thirty-five patent family members on ABBVIE ENDOCRINE INC drugs in twenty-eight countries.
Summary for Abbvie Endocrine Inc
International Patents: | 35 |
US Patents: | 2 |
Tradenames: | 3 |
Ingredients: | 1 |
NDAs: | 6 |
Drugs and US Patents for Abbvie Endocrine Inc
Expired US Patents for Abbvie Endocrine Inc
International Patents for Abbvie Endocrine Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Morocco | 31006 | ⤷ Try a Trial |
Malaysia | 148370 | ⤷ Try a Trial |
Brazil | PI0720582 | ⤷ Try a Trial |
China | 101563068 | ⤷ Try a Trial |
South Korea | 20090094272 | ⤷ Try a Trial |
Georgia, Republic of | P20125597 | ⤷ Try a Trial |
Japan | 4564098 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.